Leading medical diagnostics/research company to appear at major neuroscience
and immunohistochemistry conferences.
DEDHAM, Mass., Jan. 31 /PRNewswire/ -- Signet Laboratories, Inc., a
leading medical diagnostics/research company specializing in the development
of monoclonal antibodies and diagnostic assays for cancer, infectious disease,
and neurodegenerative disease, today announced their conference schedule for
2006.
Signet representatives will showcase new products for clinical and
research clients during major industry gatherings for both clinical pathology
and neurodegenerative disease throughout the course of the year.
Signet will be attending the following Conferences in 2006:
* United States and Canadian Academy of Pathology (USCAP)- February 13-15,
Atlanta, GA
* World Parkinson's Conference - February 22-27, Washington DC
* American Society for Neurochemistry - March 12-15, Portland, Oregon
* American Association for Cancer Research (AACR) - April 1-5, Washington
DC
* Monoclonal Antibodies - April 28, Boston, MA
* Transmissible Spongiform Encephalopathies - May 7-9, Baltimore, Maryland
* International Conference on Alzheimer's Disease and Related Disorders
(ICAD) - July 15-20, Madrid, Spain
* National Society For Histology (NSH) - September 9-14, Phoenix, Arizona
* International Academy of Pathology (IAP) - September 17-21, Montreal,
Canada
* Society for Neuroscience (SFN) - October 14-18, Atlanta, Georgia
* American College of Veterinary Pathologists (ACVP) - December 3-6,
Tucson, Arizona
Throughout 2006, Signet also plans to attend nearly a dozen major
university showcases and vendor shows, coordinated by Biotechnology Calendar
and Life Science Exhibits, LLC.
About Signet Laboratories, Inc.
Signet Laboratories, Inc. (Dedham, MA) is a leading medical
diagnostics/research company specializing in the development of monoclonal
antibodies and diagnostic assays for cancer, infectious disease, and
neurodegenerative disease. Signet was created in 1989 as a commercial spinout
of Johnson & Johnson's Cambridge Research Laboratories, Inc.
The Company was founded to continue the mission originally established at
CRL - the early detection and recurrence monitoring of patients with cancer
and infectious disease. Signet has developed patented technology for diagnosis
and recurrence monitoring and for risk assessment of asymptomatic patients in
these areas. For more than a decade, the Company has aggressively maintained
licensing and development programs, which are responsible for its broad patent
and intellectual property estate.
Contact Information
Company Contact
Colleen Scott
Signet Laboratories, Inc.
180 Rustcraft Road
Dedham, MA 02026
Phone: 781.915.1404
Fax: 781.461.2456
cscott@signetlabs.com
SOURCE Signet Laboratories, Inc.
 back to top
Related links:
http://www.signetlabs.com
CONTACT:
Colleen Scott of Signet Laboratories, Inc.,
+1-781-915-1404, cscott@signetlabs.com
|
